Arturo Molina MD - 16 Jan 2025 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Medical Officer
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Arturo Molina, MD
Issuer symbol
PTGX
Transactions as of
16 Jan 2025
Net transactions value
$0
Form type
4
Filing time
17 Jan 2025, 17:47:00 UTC
Previous filing
06 Jan 2025
Next filing
14 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Sale $0 -388 -0.44% $0.000000 87,144 16 Jan 2025 Direct F1
transaction PTGX Common Stock Sale $0 -3,252 -3.7% $0.000000 83,892 16 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.